{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:57:25Z","timestamp":1787014645923,"version":"build-2736575974"},"reference-count":97,"publisher":"Wiley","issue":"9-10","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":3923,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>A decade ago, surgery was the only satisfactory treatment modality for hepatocellular carcinoma (HCC), but it was limited only to selected cases. For the majority of cases of HCC, systemic chemotherapy was one of the few treatment alternatives, but provided only marginal benefit. In the past 20 years, diagnostic methods have improved to an extent that small HCC less than 1 cm can be detected. Moreover, non\u2010surgical treatment is available, of which regional therapy has been shown to prolong patients\u2019 survival, and may even replace surgical resection in some cases. Regional therapy is indicated for the treatment of HCC when there is no extrahepatic metastasis and the patient has adequate liver function reserve, thus permitting repeated therapy. Transcatheter hepatic arterial embolization (TAE) using various embolizers has been well documented to include controlled studies. However, it is not indicated for patients with thrombosed main portal veins. Its therapeutic effect is also doubtful when the tumour is infiltrative in nature or is hypovascular, too large or too small. Additional chemotherapeutic agents mixed into the embolizer with lipiodol and degraded starch microspheres or styrene\u2010maleic acid\u2010neocarzinostatin in which chemotherapeutic agents are embedded, are used with a better response, but the survival rate has not shown significant improvement. Ultrasound\u2010guided local injection therapy is another new method of treatment of HCC. Of these techniques, percutaneous ethanol injection therapy (PEIT) is widely used with excellent results for small, encapsulated tumours in livers with less than three HCC. Percutaneous ethanol injection therapy can also be used in cases with portal vein thrombosis, but it is not suitable for patients having coagulopathy or ascites. Using acetic acid, OK\u2010432, interferon or anti\u2010cancer drugs in the injection therapy shows no further benefit over ethanol alone. Transcatheter echoguided thermotherapy or cryotherapy has been reported in small series of patients, as has target therapy with immune or radiotherapy and conformal radiotherapy. Preliminary studies show encouraging results. Systemic therapy with either single drug or multidrugs is ineffective, with a response rate of less than 20%. Immunotherapy, such as with interferon or other cytokines, is not beneficial. Hormone therapy has not been promising, except for treatment with tamoxifen, which has been reported to show some beneficial effect. Gene therapy is still in its infancy. In summary, recent progress in non\u2010surgical treatment of HCC has resulted in a breakthrough of regional therapy looking quite promising. Moreover, a combination of different types of regional therapies may yield better outcomes in selected individuals.<\/jats:p>","DOI":"10.1111\/j.1440-1746.1997.tb00516.x","type":"journal-article","created":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T20:53:08Z","timestamp":1205182388000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Non\u2010surgical treatment of hepatocellular carcinoma"],"prefix":"10.1111","volume":"12","author":[{"given":"DENG\u2010YN","family":"LIN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHI\u2010MING","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUN\u2010FAN","family":"LIAW","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"705","article-title":"Hepatocellular carcinoma: One of the world's most common malignancies","volume":"233","author":"Cook GC","year":"1985","journal-title":"Am. J. Med"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1989.01410090031006"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0016-5085(86)90919-4","article-title":"Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis: A prospective study","volume":"70","author":"Liaw YF","year":"1986","journal-title":"Gastroenterology"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840160314"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180517"},{"key":"e_1_2_1_7_2","first-page":"194","article-title":"The effect of percutaneous ethanol injection therapy on small hepatocellular carcinoma is comparable to that of hepatectomy","volume":"89","author":"Kotoh K","year":"1994","journal-title":"Am. J. Gastroenterol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000227561"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199403000-00003"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00316978"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841869409098452"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.6.1323"},{"key":"e_1_2_1_13_2","first-page":"118","volume-title":"Proceedings of the International Symposium on Chemotherapy of Cancer","author":"Brennan M","year":"1964"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.71"},{"key":"e_1_2_1_15_2","first-page":"120","article-title":"A phase II study of etoposide in patients with hepatocellular carcinoma by the Tokyo Liver Cancer Chemotherapy Study Group","volume":"19","author":"Yoshino M","year":"1989","journal-title":"Jpn. J. Clin. Oncol"},{"key":"e_1_2_1_16_2","first-page":"311","article-title":"Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangioma: A Southeastern Cancer Study Group Trial","volume":"70","author":"Ravy MJ","year":"1986","journal-title":"Cancer Treat. Rep"},{"key":"e_1_2_1_17_2","first-page":"286","article-title":"Phase II clinical trial of elliptinium in advanced hepatocellular carcinoma","volume":"39","author":"Lin DY","year":"1992","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000227434"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197510)36:4<1250::AID-CNCR2820360410>3.0.CO;2-X"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19801215)46:12<2717::AID-CNCR2820461230>3.0.CO;2-T"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19851215)56:12<2751::AID-CNCR2820561205>3.0.CO;2-O"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880801)62:3<479::AID-CNCR2820620306>3.0.CO;2-L"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199508000-00003"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(87)80545-7"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197705)39:5<1930::AID-CNCR2820390503>3.0.CO;2-7"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.jjco.a039083","article-title":"Phase II study of co\u2010administration of uracil and Tegafur (UFT) in hepatocellular carcinoma","volume":"15","author":"Tokyo Liver Cancer Chemotherapy Study Group","year":"1985","journal-title":"Jpn. J. Clin. Oncol"},{"key":"e_1_2_1_27_2","first-page":"88","article-title":"Phase II trial of oral 4\u2032 demethoxydaunorubicin (DMDR) in patients with primary liver carcinoma","volume":"4","author":"Cheng E","year":"1985","journal-title":"Proc. Am. Soc. Clin. Oncol"},{"key":"e_1_2_1_28_2","first-page":"695","article-title":"Establishment and serial quantification of intrahepatic xenografts on human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance","volume":"2","author":"Leveille\u2010Webster CR","year":"1996","journal-title":"Clin. Cancer Res"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00323-B"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000227516"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1995.tb01598.x"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80138-2"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210610"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90402-6"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<872::AID-CNCR10>3.0.CO;2-0"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80038-7"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<635::AID-CNCR8>3.0.CO;2-F","article-title":"Phase II study of flutamide in the treatment of hepatocellular carcinoma","volume":"7","author":"Chao Y","year":"1996","journal-title":"Cancer"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1985.156"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000227144"},{"key":"e_1_2_1_40_2","first-page":"251","article-title":"Tumor site\u2010directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma\u2010associated antigens","volume":"11","author":"Shouval D","year":"1993","journal-title":"Progr. Liver Dis"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80044-1"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220528"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230611"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(95)04040-4"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606133342402"},{"key":"e_1_2_1_46_2","first-page":"552","article-title":"The herbal medicine Inchin\u2010ko\u2010to inhibits liver cell apoptosis induced by transforming growth factor \u03b21","volume":"23","author":"Yamamota M","year":"1996","journal-title":"Hepatology"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00689454"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199506000-00014"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80445-5"},{"key":"e_1_2_1_50_2","first-page":"116","article-title":"Clinical evaluation of transcatheter arterial embolization and one\u2010shot chemotherapy in hepatocellular carcinoma","volume":"35","author":"Soga K","year":"1988","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1159\/000227477"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841868909111250"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1995.tb01086.x"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860315)57:6<1184::AID-CNCR2820570620>3.0.CO;2-9"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90436-2"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940701)74:1<16::AID-CNCR2820740105>3.0.CO;2-V"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(06)80115-X"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800811105"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190508"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950515)75:10<2427::AID-CNCR2820751007>3.0.CO;2-J"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950901)76:5<736::AID-CNCR2820760505>3.0.CO;2-Q"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.193.1.8090924"},{"key":"e_1_2_1_63_2","first-page":"937","article-title":"Palliative chemoembolization of hepatocellular carcinoma with mitoxantrone, lipiodol, and gelfoam. A phase II study","volume":"16","author":"Civalleri D","year":"1996","journal-title":"Anticancer Res"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.1.125"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19941101)74:9<2449::AID-CNCR2820740910>3.0.CO;2-4"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505113321903"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199426040-00004"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686668"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686667"},{"key":"e_1_2_1_70_2","first-page":"332","article-title":"Hepatic artery injection of yttrium\u201090\u2010lipiodol: Biodistribution in rats with hepatoma","volume":"37","author":"Wang SJ","year":"1996","journal-title":"J. Nucl. Med"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951201)76:11<2202::AID-CNCR2820761105>3.0.CO;2-8"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.188.1.8390073"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.163.1.3029806"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19911001)68:7<1524::AID-CNCR2820680711>3.0.CO;2-O"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.193.3.7972818"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230509"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.190.1.8259428"},{"key":"e_1_2_1_78_2","first-page":"463","article-title":"Treatment of malignant tumors using percutaneous hot saline injections. Feasibility study and preliminary results","volume":"90","author":"Velti A","year":"1995","journal-title":"Radiol. Med"},{"key":"e_1_2_1_79_2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/030089168607200514","article-title":"Percutaneous interstitial chemotherapy of a small hepatocellular carcinoma under ultrasound guidance","volume":"72","author":"Livraghi T","year":"1986","journal-title":"Tumori"},{"key":"e_1_2_1_80_2","first-page":"365","article-title":"Response of rat Morris hepatoma to intra\u2010tumoral administration of high dose recombinant human necrosis factor\u2010\u03b2","volume":"14","author":"Ha XF","year":"1995","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"e_1_2_1_81_2","first-page":"958","article-title":"Ultrasound\u2010guided internal radiotherapy using yttrium\u201090\u2010glass microspheres for liver malignancies","volume":"37","author":"Tian JH","year":"1996","journal-title":"J. Nucl. Med"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.197.1.7568806"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.188.1.8390070"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01655321"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90069-G"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.34.302"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940801)74:3<817::AID-CNCR2820740306>3.0.CO;2-8"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.164.5.7717224"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613057"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.196.1.7540310"},{"key":"e_1_2_1_91_2","first-page":"97","article-title":"Percutaneous ultrasound\u2010guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma","volume":"8","author":"Rossi S","year":"1993","journal-title":"J. Intervent. Radiol"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.185.2.1329143"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.197.3.7480761"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01519987"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002620050262"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199506000-00005"},{"key":"e_1_2_1_97_2","first-page":"1437","article-title":"Update on regional treatment for hepatobiliary malignancies","volume":"11","author":"Curley SA.","year":"1995","journal-title":"Jpn. J. Cancer Chemother"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91739-X"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.1997.tb00516.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.1997.tb00516.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T08:04:06Z","timestamp":1693382646000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.1997.tb00516.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":97,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1111\/j.1440-1746.1997.tb00516.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.1997.tb00516.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}